News|Articles|December 20, 2024
Molecular Properties of PROTACs and the Relationship to Formulation Design
Author(s)Bend BioScience
Analyzation of a diverse set of PROTAC (Proteolysis Targeting Chimeras – a class of TPDs) structures and their calculated properties, identifying key structure-property trends that contribute to low oral bioavailability.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
2
FDA, Duke University Planning Epinephrine Access Workshop for December
3
How ten23 health is Advancing Patient-Centric Drug Delivery
4
PharmTech Weekly News Roundup — Week of November 24, 2025
5
